Neuros Medical, Inc. announced that it has received approval from the United States Food and Drug Administration (FDA) for its Altius® Direct Electrical Nerve...
Invenra Inc. is pleased to announce that its innovative bispecific antibody, INV724, developed for the treatment of neuroblastoma, has been awarded both Rare Pediatric...
Masimo announced that the Masimo W1 medical watch has received FDA 510(k) clearance for connectivity, allowing it to be integrated with the Masimo SafetyNet® comprehensive telemonitoring...
Sandoz, the global leader in generic and biosimilar medicines, announced that the US Food and Drug Administration (FDA) has approved Enzeevu™ (aflibercept-abzv) 2 mg...
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced a strategic...
